Status:
COMPLETED
Treatment of Portal Vein Tumor Thrombus After Hepatocellular Carcinoma Resection
Lead Sponsor:
Eastern Hepatobiliary Surgery Hospital
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Hepatectomy is still the treatment of choice for hepatocellular carcinoma. Part of the patients may present portal vein tumor thrombus (PVTT) after resection. PVTT might lead to upper gastrointestinal...
Detailed Description
Hepatectomy is still the treatment of choice for hepatocellular carcinoma, but the prognosis is not agreeable. Part of the patients may present portal vein tumor thrombus (PVTT) after resection. PVTT ...
Eligibility Criteria
Inclusion
- PVTT after liver resection was diagnosed with at least two types of imaging findings, such as CT, MRI or color doplor findings.
- The functions of the kidney, heart and lung and the routine test of the blood are in good condition.
- The liver function is of grade A or B in Child-Pugh classification.
- The patient is eligible of the trial and will show consent to the test.
Exclusion
- any of the parameters. WBC less than 2000/ml, Hb less than 90g/L or PLT less than 50000/ml.
- disfunction of the heart, lung, kidney, or brain.
- any other disease might affect the trial .
- the patients would not sign the consent to the trial.
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00825669
Start Date
December 1 2008
End Date
December 1 2010
Last Update
April 1 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eastern Hepatobiliary Surgery Hospital
Shanghai, Shanghai Municipality, China, 200438